Notably, Pentimalli and coworkers could demonstrate that the combined used of the pan-CDK inhibitor roscovitine, potently active against CDK2, and the AKT inhibitor VIII (AKTiVIII) was synergic in lung cancer and mesothelioma cells [3]. Here, AKT1 is linked to lung carcinoma.